#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13314	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2138	614.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1399	1399	C	768	C	726	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13314	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2138	614.8	0	HET	.	.	.	C451T	.	451	451	C	666	666	C	774	C,T	423,326	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24960	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3512	704.0	0	.	n	.	0	T695C	SNP	695	695	T	924	924	C	744	C	719	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24960	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3512	704.0	0	.	n	.	0	A1638G	SNP	1638	1638	A	1867	1867	G	766	G,A	526,213	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24960	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3512	704.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2200	2200	C	728	C,G	692,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24960	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3512	704.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2274	2274	A	664	A	644	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24960	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3512	704.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2826	2826	C	738	C	714	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24960	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3512	704.0	0	HET	.	.	.	T2085C	.	2085	2085	T	2314	2314	T	692	T,C	531,136	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1638	folP	855	855	100.0	folP.l6.c4.ctg.1	1555	103.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1061	1063	AGC	178;177;177	A;G;C	173;173;173	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5050	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3347	149.7	1	SNP	p	S91F	1	.	.	271	273	TTC	586	588	TTC	181;182;184	T;T;C	176;178;178	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5050	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3347	149.7	1	SNP	p	D95G	1	.	.	283	285	GGC	598	600	GGC	177;176;174	G;G;C	169;170;169	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5050	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3347	149.7	1	SNP	p	G95N	0	.	.	283	285	GGC	598	600	GGC	177;176;174	G;G;C	169;170;169	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1450	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1298	110.5	1	SNP	p	G45D	0	.	.	133	135	GGC	473	475	GGC	182;180;178	G;G;C	175;176;174	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	712	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	958	73.6	0	.	n	.	0	A197.	DEL	197	197	A	593	593	A	175	A	167	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4642	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2922	157.5	1	SNP	p	D86N	0	.	.	256	258	GAC	574	576	GAC	166;166;168	G;A,C;C	158;151,1;160	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4642	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2922	157.5	1	SNP	p	R87W	0	.	.	259	261	CGT	577	579	CGT	169;165;164	C;G;T	160;156;153	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4642	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2922	157.5	1	SNP	p	R87I	0	.	.	259	261	CGT	577	579	CGT	169;165;164	C;G;T	160;156;153	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4642	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2922	157.5	1	SNP	p	S87R	1	.	.	259	261	CGT	577	579	CGT	169;165;164	C;G;T	160;156;153	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4642	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2922	157.5	1	SNP	p	S88P	0	.	.	262	264	TCC	580	582	TCC	161;164;166	T;C;C	151;157;158	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3714	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2675	137.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1500	1502	GGC	181;178;177	G,C;G;C	172,1;168;168	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3644	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2362	152.4	1	SNP	p	A311V	0	.	.	931	933	GCC	1272	1274	GCC	212;215;214	G;C;C	203;206;206	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3644	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2362	152.4	1	SNP	p	I312M	1	.	.	934	936	ATG	1275	1277	ATG	215;213;212	A;T;G	208;206;203	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3644	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2362	152.4	1	SNP	p	T316P	0	.	.	946	948	ACC	1287	1289	ACC	212;213;216	A;C;C	202;206;206	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3644	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2362	152.4	1	SNP	p	V316T	1	.	.	946	948	ACC	1287	1289	ACC	212;213;216	A;C;C	202;206;206	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3644	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2362	152.4	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1788	1790	ACC	175;175;175	A;C;C	164;169;168	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3644	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2362	152.4	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1842	1844	GCG	166;167;170	G;C,G;G	159;157,1;163	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3644	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2362	152.4	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1842	1844	GCG	166;167;170	G;C,G;G	159;157,1;163	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3644	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2362	152.4	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1965	1967	GGT	160;158;156	G;G;T	150;150;145	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3644	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2362	152.4	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1974	1976	AGC	150;149;147	A,G;G;C	136,4;141;139	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3644	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2362	152.4	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1992	1994	CCG	108;114;114	C,G;C,G;G	93,6;98,3;98	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5242	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3111	166.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1651	1653	CCG	182;180;176	C;C;G	169;171;162	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2446	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1680	143.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	488	488	C	166	C	158	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2492	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1555	158.5	0	.	p	.	0	I45L	NONSYN	133	135	ATT	375	377	CTT	189;189;190	C,G,A;T;T	174,6,2;182;182	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2492	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1555	158.5	0	.	p	.	0	G48E	NONSYN	142	144	GGA	384	386	GAA	190;192;194	G;A,G;A	180;180,3;182	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2492	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1555	158.5	0	.	p	.	0	S217G	NONSYN	649	651	AGT	891	893	GGT	205;206;205	G,A;G;T,C	194,5;203;199,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2492	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1555	158.5	1	SNP	p	G120K	1	.	.	358	360	AAG	600	602	AAG	180;179;179	A;A;G,A	168;172;169,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2492	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1555	158.5	1	SNP	p	A121N	1	.	.	361	363	AAC	603	605	AAC	177;177;178	A;A;C,A	168;171;166,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2492	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1555	158.5	1	SNP	p	N121D	0	.	.	361	363	AAC	603	605	AAC	177;177;178	A;A;C,A	168;171;166,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8534	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	4866	173.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1080	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1039	102.8	1	SNP	p	V57M	1	.	.	169	171	ATG	512	514	ATG	200;200;197	A;T;G	196;194;192	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
